Search
for
Sort by
Research 91–120 of 131
- Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Genome-wide association study of atopic and autoimmune comorbidities in alopecia areata
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Ophthalmologic Comorbidities in Alopecia Areata
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Research progress in the treatment of non-scarring alopecia: mechanism and treatment
- Alopecia Areata Incognita: Current Evidence
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
- Pathogenesis and regenerative therapy in vitiligo and alopecia areata: focus on hair follicle
- Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences
- Recent advances in the genetics of alopecia areata
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Alopecia areata in children: an overview of clinical features and recent treatment options
- Editor's evaluation: Involvement of ILC1-like innate lymphocytes in human autoimmunity, lessons from alopecia areata
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- A perspective on predictive markers of alopecia
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- Proceedings of the Ninth World Congress for Hair Research (2015)
- Recent Advances in the Pathogenesis of Autoimmune Hair Loss Disease Alopecia Areata
- Clinical perspectives on the age-related increase of immunosuppressive activity
- Pathomechanisms of immune-mediated alopecia
- An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
- Alopecia: A review of laser and light therapies
- The Genetics of Human Skin Disease
- The Molecular Revolution in Cutaneous Biology: Noncoding RNAs: New Molecular Players in Dermatology and Cutaneous Biology
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- MHC Class I-Like MILL Molecules Are β2-Microglobulin-Associated, GPI-Anchored Glycoproteins That Do Not Require TAP for Cell Surface Expression
- Application of Baricitinib in Dermatology
- Autoantigen Discovery in the Hair Loss Disorder, Alopecia Areata: Implication of Post-Translational Modifications